Ann: INV103 ala-Cpn10 clinical trial in lupus complete, page-3

Finally we have one lot of results released!!!
Fantastic to see the safety is still there even with a dosing increase of 10 fold compared to what had been done previously.
I'm not getting to bogged down in the biomarkers as the primary goal of this study was to increase the dosage to see if it is still safe, keep in mind there was only 28 patients so too small to factor in biological changes. Now we can have the larger and longer study into Cpn10 for autoimmune diseases. Lets see who we can partner up with and drive this science further!!